Zoledronic Acid Injection, Solution, Concentrate
Product Images NDC 23155-170
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Zoledronic Acid (NDC 23155-170). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Heritage Pharmaceuticals Inc. D/b/a Avet Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
F8f249ce 41d0 4cff 8185 0fd2ed393361 02
F8f249ce 41d0 4cff 8185 0fd2ed393361 03
F8f249ce 41d0 4cff 8185 0fd2ed393361 04
F8f249ce 41d0 4cff 8185 0fd2ed393361 05
This text appears to be a description of a medication. The medication is identified as Zoledronic Acid, available in the form of an injection with a concentration of 4 mg/5 mL. It is indicated for intravenous infusion, and must not be directly injected. The dose needs to be diluted. The medication is packaged in single-dose vials, each containing 4.264 mg of zoledronic acid monohydrate, which is equivalent to 4 mg of zoledronic acid on an anhydrous basis. Other ingredients include mannitol, USP (220 mg), water for injection USP, and sodium citrate USP (used to adjust pH). It is advised not to mix this medication with calcium-containing infusion solutions. Storage temperature is recommended at 25°C (77°F) with excursions permitted between 15-30°C (59-86°F). Any unused portion should be discarded. The manufacturer is Emcure Pharmaceuticals Ltd., located in Sanand, Ahmedabad, India. The distributor is Avet Pharmaceuticals Inc. The text also includes some non-relevant information about a non-varnished area that is not applicable for this description.*
F8f249ce 41d0 4cff 8185 0fd2ed393361 06
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.